Pharmafile Logo
Pharmafocus logo
Advanced Search

Sandoz files Amgen biosimilar drug for osteoporosis

February 8, 2023
Research and Development

Switzerland-based Sandoz has filed a proposed biosimilar of Amgen’s osteoporosis drug Prolia/Xgeva with the FDA. According to Sandoz, over 10 …

News

Cell and Gene Therapy Catapult to play significant role in establishing one of the largest life sciences campuses in Europe

February 8, 2023
Business Services

London, 8th February 2023: The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in …

News
Press release

Sequana Medical announces the successful completion of pre-clinical studies with its second-generation DSR product for congestive heart failure

February 8, 2023
Business Services

Ghent, Belgium – 08 February 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana

News
Press release

AstraZeneca’s Forxiga approved in EU for chronic heart failure

February 7, 2023
Medical Communications

AstraZeneca has announced that its drug, Forxiga, has been approved in the EU for the treatment of symptomatic chronic heart …

News

Genentech shares positive results from global phase 3 trials for crovalimab in PNH

February 7, 2023
Medical Communications

Following the global COMMODORE 2 study, Genentech has announced positive data for crovalimab in treating patients with paroxysmal nocturnal haemoglobinuria …

News

4D Molecular Therapeutics’ Fabry Gene Therapy put on FDA-mandated hold

February 7, 2023
Research and Development

4D Molecular Therapeutics has had its gene therapy programme 4D-310 put on clinical hold by the FDA after adverse side …

News

Strong sales of Basilea’s Cresemba triggers second sales milestone payment from Pfizer

February 7, 2023
Sales and Marketing

Swiss commercial-stage biopharmaceutical company Basilea Pharmaceutica Ltd has announced that continued high sales of its drug Cresemba (isavuconazole) in China …

News

Sage Therapeutics and Biogen Announce FDA Accepts Filing of New Drug Application and Grants Priority Review of Zuranolone in the Treatment of Major Depressive Disorder and Postpartum Depression

February 7, 2023
Business Services

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Sage Therapeutics, Inc. (Nasdaq: SAGE) and Biogen Inc. (Nasdaq: BIIB) announced the U.S. Food and Drug Administration (FDA) has accepted …

News
Press release

Oxford Science Enterprises strengthens Life Sciences investment team with appointment of Sanne de Jongh as Partner

February 7, 2023
Business Services

Oxford, UK: February 7, 2023 – Oxford Science Enterprises (OSE), the independent investment company created to found, fund and build transformational businesses …

News
Press release

Chong Kun Dang Pharm Licenses Synaffix ADC Technology, Adds Novel ADC Candidate to Oncology Pipeline

February 6, 2023
Business Services

THE NETHERLANDS and SOUTH KOREA, 6 February 2023 — Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform …

News
Press release

Oxford University scientists’ AI diagnostic test accurately identifies known respiratory viruses in minutes

February 6, 2023
Business Services

February 6th, 2023 – Oxford, United Kingdom – Nicolas Shiaelis and 

News
Press release

Patients with hidradenitis suppurativa experienced sustained efficacy and symptom improvement at one year when treated with Novartis Cosentyx®

February 6, 2023
Business Services

Basel, February 4, 2023 – Novartis announced today that The Lancet has published long-term data from the pivotal SUNSHINE and …

News
Press release

SPR Therapeutics gains FDA extended approval for pain management system

February 6, 2023
Research and Development

Pain management medical device company SPR Therapeutics has obtained expanded approval from the FDA for its SPRINT Peripheral Nerve System …

News

Australia’s TGA approves psychedelics to treat mental health conditions

February 6, 2023
Research and Development

Australia’s Therapeutic Goods Administration (TGA) has announced its approval of the use of psychedelics to treat certain mental health conditions. …

News

Daiichi Sankyo to build Japan’s first factory for mRNA COVID-19 vaccines

February 6, 2023
Manufacturing and Production

Daiichi Sankyo have announced its plans to build Japan’s first factory for mRNA COVID-19 vaccines. The new facility is expected …

News

Boston Scientific fined $42m over patent infringement

February 6, 2023
Medical Communications

A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …

News

Businesses from the UK are in the top four foreign investors in Flanders in 2022

February 3, 2023
Business Services

Investment figures released this week by Flanders Investment & Trade show that UK businesses are continuing to make significant investments …

News
Press release

IMFINZI (DURVALUMAB) IN COMBINATION WITH GEMCITABINE AND CISPLATIN APPROVED IN GREAT BRITAIN AS A FIRST-LINE TREATMENT FOR ADULT PATIENTS WITH LOCALLY ADVANCED, UNRESECTABLE OR METASTATIC BILIARY TRACT CANCER

February 3, 2023
Business Services

London, UK, Thursday 2 February 2023 – AstraZeneca today announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has …

News
Press release

MHRA Approves RINVOQ®▼ (upadacitinib) as First Oral Advanced Therapy to Treat Adults with Moderately to Severely Active Crohn’s Disease

February 3, 2023
Business Services

MAIDENHEAD, UK, 01 February 2023 – AbbVie (NYSE: ABBV) today announced that the UK Medicines and Healthcare products Regulatory Agency …

News
Press release

Phlo raises £10m to spearhead digital transformation in pharmacy sector

February 3, 2023
Business Services

[Glasgow, Scotland]  Phlo, UK digital pharmacy leaders, have closed a £10m Series A round led by family office Thairm Bio.   …

News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025